30 June 2017

A review of the evidence assessing impact of social prescribing

A review of the evidence assessing impact of social prescribing on healthcare demand and cost implications.
University of Westminster June 2017
  • It is estimated that around 20% of patients consult their GP for what is primarily a social problem. It has been suggested that referral to a social prescribing service could reduce this pressure. This systematic review critically appraises the current evidence as to whether social prescribing reduces the demand for health services and is cost effective. 
  • Fourteen papers were examined. 
    • Seven looked at the ffect on demand for general practice, reporting an average 28% reduction in demand for GP services.
    • Five studies looked at the effect on A&E attendances and reported an average fall of 24% in attendance
    • Five studies looked at demand on other secondary care services and reported significant reductsion in demand. 
    • Value for money assessments in eight studies were methodologically unsatisfactory.
    • Anaysis of Social Return on Investment in four studies suggest SROI was £2.3 per £1 invested in the first year.
  • Poor quality of data means all results have to be interpreted with caution.